Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. (Q54001348)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. |
scientific article |
Statements
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. (English)
1 reference
Kramer K
1 reference
Gerald WL
1 reference
Kushner BH
1 reference
Larson SM
1 reference
Hameed M
1 reference
Cheung NK
1 reference
1 January 2001
1 reference
36
1 reference
1
1 reference
194-196
1 reference
Identifiers
1 reference